Furui Co.,Ltd(SZ:300049) Xin Lang Cai Jing·2025-09-03 02:40Core Viewpoint - Furu Pharmaceutical Co., Ltd. has seen a stock price increase of 5.38% to 66.38 CNY per share, with a total market capitalization of 17.589 billion CNY as of September 3 [1] Company Overview - Furu Pharmaceutical, established on December 26, 2001, and listed on January 20, 2010, is located in Chaoyang District, Beijing. The company specializes in the production and sales of drugs in the liver disease sector, as well as instrument research and sales, and medical services [1] - The revenue composition of Furu Pharmaceutical is as follows: 67.57% from equipment and technology, 27.47% from pharmaceuticals, 4.30% from medical services, and 0.65% from other sources [1] Shareholder Information - Southern Fund's Southern Medical Health Flexible Allocation Mixed A Fund (000452) is among the top ten circulating shareholders of Furu Pharmaceutical, having increased its holdings by 159,000 shares in the second quarter, totaling 3.8899 million shares, which represents 1.66% of the circulating shares [2] - The fund has achieved a year-to-date return of 55.82%, ranking 462 out of 8,180 in its category, and a one-year return of 55.38%, ranking 2,082 out of 7,967 [2] Fund Manager Performance - The fund manager of Southern Medical Health Flexible Allocation Mixed A Fund is Wang Zhengjiao, who has been in the position for 7 years and 41 days. The fund's total asset size is 2.417 billion CNY, with the best return during Wang's tenure being 74.43% and the worst being -53.83% [3] Fund Holdings - Southern Medical Health Flexible Allocation Mixed A Fund has Furu Pharmaceutical as its sixth-largest holding, with 5.22% of the fund's net value allocated to this stock [4]